APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Circovirus Diseases Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Porcine Circovirus Diseases Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchPorcine Circovirus Diseases Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Circovirus Diseases Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Porcine Circovirus Diseases Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Circovirus Diseases Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Circovirus Diseases Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Porcine Circovirus Diseases Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Circovirus Diseases Vaccine include Zoetis, Yebio Bioengineering, Pulike Biological Engineering, Nannong Hi-Tech, Merck, Jinyu Bio-technology, Jinhe Biotechnology, Hile Bio-Technology and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Circovirus Diseases Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Circovirus Diseases Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Circovirus Diseases Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Circovirus Diseases Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Circovirus Diseases Vaccine Segment by Company

Zoetis

Yebio Bioengineering

Pulike Biological Engineering

Nannong Hi-Tech

Merck

Jinyu Bio-technology

Jinhe Biotechnology

Hile Bio-Technology

Ceva

Boehringer Ingelheim

Porcine Circovirus Diseases Vaccine Segment by Type

Inactivated Vaccine

Genetically Engineered Vaccine

Porcine Circovirus Diseases Vaccine Segment by Application

Piglet

Fertile Sow

Porcine Circovirus Diseases Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus Diseases Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus Diseases Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus Diseases Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Circovirus Diseases Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Circovirus Diseases Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Circovirus Diseases Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Porcine Circovirus Diseases Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Porcine Circovirus Diseases Vaccine Industry Trends Table 2. Porcine Circovirus Diseases Vaccine Industry Drivers Table 3. Porcine Circovirus Diseases Vaccine Industry Opportunities and Challenges Table 4. Porcine Circovirus Diseases Vaccine Industry Restraints Table 5. Global Porcine Circovirus Diseases Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Porcine Circovirus Diseases Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Manufacturers Table 9. Global Porcine Circovirus Diseases Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Porcine Circovirus Diseases Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Porcine Circovirus Diseases Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Porcine Circovirus Diseases Vaccine Manufacturers, Product Type & Application Table 13. Global Porcine Circovirus Diseases Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Circovirus Diseases Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccine Table 17. Major Manufacturers of Genetically Engineered Vaccine Table 18. Global Porcine Circovirus Diseases Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Porcine Circovirus Diseases Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Porcine Circovirus Diseases Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Porcine Circovirus Diseases Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Piglet Table 29. Major Manufacturers of Fertile Sow Table 30. Global Porcine Circovirus Diseases Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Porcine Circovirus Diseases Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Porcine Circovirus Diseases Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Porcine Circovirus Diseases Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Porcine Circovirus Diseases Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Porcine Circovirus Diseases Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Porcine Circovirus Diseases Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Porcine Circovirus Diseases Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Region (2027-2032) Table 62. Zoetis Company Information Table 63. Zoetis Business Overview Table 64. Zoetis Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zoetis Porcine Circovirus Diseases Vaccine Product Portfolio Table 66. Zoetis Recent Development Table 67. Yebio Bioengineering Company Information Table 68. Yebio Bioengineering Business Overview Table 69. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolio Table 71. Yebio Bioengineering Recent Development Table 72. Pulike Biological Engineering Company Information Table 73. Pulike Biological Engineering Business Overview Table 74. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolio Table 76. Pulike Biological Engineering Recent Development Table 77. Nannong Hi-Tech Company Information Table 78. Nannong Hi-Tech Business Overview Table 79. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolio Table 81. Nannong Hi-Tech Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Porcine Circovirus Diseases Vaccine Product Portfolio Table 86. Merck Recent Development Table 87. Jinyu Bio-technology Company Information Table 88. Jinyu Bio-technology Business Overview Table 89. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolio Table 91. Jinyu Bio-technology Recent Development Table 92. Jinhe Biotechnology Company Information Table 93. Jinhe Biotechnology Business Overview Table 94. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolio Table 96. Jinhe Biotechnology Recent Development Table 97. Hile Bio-Technology Company Information Table 98. Hile Bio-Technology Business Overview Table 99. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolio Table 101. Hile Bio-Technology Recent Development Table 102. Ceva Company Information Table 103. Ceva Business Overview Table 104. Ceva Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Ceva Porcine Circovirus Diseases Vaccine Product Portfolio Table 106. Ceva Recent Development Table 107. Boehringer Ingelheim Company Information Table 108. Boehringer Ingelheim Business Overview Table 109. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolio Table 111. Boehringer Ingelheim Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Porcine Circovirus Diseases Vaccine Distributors List Table 115. Porcine Circovirus Diseases Vaccine Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Porcine Circovirus Diseases Vaccine Product Image Figure 2. Global Porcine Circovirus Diseases Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Circovirus Diseases Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Circovirus Diseases Vaccine Sales (2021-2032) & (k units) Figure 5. Global Porcine Circovirus Diseases Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Porcine Circovirus Diseases Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccine Image Figure 9. Genetically Engineered Vaccine Image Figure 10. Global Porcine Circovirus Diseases Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Porcine Circovirus Diseases Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Porcine Circovirus Diseases Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Piglet Image Figure 17. Fertile Sow Image Figure 18. Global Porcine Circovirus Diseases Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Porcine Circovirus Diseases Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Porcine Circovirus Diseases Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Porcine Circovirus Diseases Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Porcine Circovirus Diseases Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Porcine Circovirus Diseases Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Porcine Circovirus Diseases Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Porcine Circovirus Diseases Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Porcine Circovirus Diseases Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Porcine Circovirus Diseases Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Genetically Engineered Vaccine
Applications
  • Piglet
  • Fertile Sow
Companies covered
  • Zoetis
  • Yebio Bioengineering
  • Pulike Biological Engineering
  • Nannong Hi-Tech
  • Merck
  • Jinyu Bio-technology
  • Jinhe Biotechnology
  • Hile Bio-Technology
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Circovirus Diseases Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Circovirus Diseases Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Porcine Circovirus Diseases Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Porcine Circovirus Diseases Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Porcine Circovirus Diseases Vaccine Market Dynamics
  1. 2.1 Porcine Circovirus Diseases Vaccine Industry Trends
  2. 2.2 Porcine Circovirus Diseases Vaccine Industry Drivers
  3. 2.3 Porcine Circovirus Diseases Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Circovirus Diseases Vaccine Industry Restraints
3 Porcine Circovirus Diseases Vaccine Market by Manufacturers
  1. 3.1 Global Porcine Circovirus Diseases Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Porcine Circovirus Diseases Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Porcine Circovirus Diseases Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Porcine Circovirus Diseases Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Circovirus Diseases Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Porcine Circovirus Diseases Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Porcine Circovirus Diseases Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Circovirus Diseases Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Circovirus Diseases Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Circovirus Diseases Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Circovirus Diseases Vaccine Market by Type
  1. 4.1 Porcine Circovirus Diseases Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Genetically Engineered Vaccine
  4. 4.2 Global Porcine Circovirus Diseases Vaccine Sales by Type
  5. 4.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Porcine Circovirus Diseases Vaccine Revenue by Type
  9. 4.3.1 Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2032)
5 Porcine Circovirus Diseases Vaccine Market by Application
  1. 5.1 Porcine Circovirus Diseases Vaccine Application Introduction
  2. 5.1.1 Piglet
  3. 5.1.2 Fertile Sow
  4. 5.2 Global Porcine Circovirus Diseases Vaccine Sales by Application
  5. 5.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Circovirus Diseases Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Porcine Circovirus Diseases Vaccine Revenue by Application
  9. 5.3.1 Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2032)
6 Global Porcine Circovirus Diseases Vaccine Sales by Region
  1. 6.1 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Circovirus Diseases Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Porcine Circovirus Diseases Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Porcine Circovirus Diseases Vaccine Revenue by Region
  1. 7.1 Global Porcine Circovirus Diseases Vaccine Revenue by Region
  2. 7.1.1 Global Porcine Circovirus Diseases Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Porcine Circovirus Diseases Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Porcine Circovirus Diseases Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Porcine Circovirus Diseases Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Porcine Circovirus Diseases Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Porcine Circovirus Diseases Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Porcine Circovirus Diseases Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Yebio Bioengineering
  8. 8.2.1 Yebio Bioengineering Company Information
  9. 8.2.2 Yebio Bioengineering Business Overview
  10. 8.2.3 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolio
  12. 8.2.5 Yebio Bioengineering Recent Developments
  13. 8.3 Pulike Biological Engineering
  14. 8.3.1 Pulike Biological Engineering Company Information
  15. 8.3.2 Pulike Biological Engineering Business Overview
  16. 8.3.3 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolio
  18. 8.3.5 Pulike Biological Engineering Recent Developments
  19. 8.4 Nannong Hi-Tech
  20. 8.4.1 Nannong Hi-Tech Company Information
  21. 8.4.2 Nannong Hi-Tech Business Overview
  22. 8.4.3 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolio
  24. 8.4.5 Nannong Hi-Tech Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Porcine Circovirus Diseases Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Jinyu Bio-technology
  32. 8.6.1 Jinyu Bio-technology Company Information
  33. 8.6.2 Jinyu Bio-technology Business Overview
  34. 8.6.3 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolio
  36. 8.6.5 Jinyu Bio-technology Recent Developments
  37. 8.7 Jinhe Biotechnology
  38. 8.7.1 Jinhe Biotechnology Company Information
  39. 8.7.2 Jinhe Biotechnology Business Overview
  40. 8.7.3 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolio
  42. 8.7.5 Jinhe Biotechnology Recent Developments
  43. 8.8 Hile Bio-Technology
  44. 8.8.1 Hile Bio-Technology Company Information
  45. 8.8.2 Hile Bio-Technology Business Overview
  46. 8.8.3 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolio
  48. 8.8.5 Hile Bio-Technology Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Porcine Circovirus Diseases Vaccine Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Circovirus Diseases Vaccine Value Chain Analysis
  2. 9.1.1 Porcine Circovirus Diseases Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Circovirus Diseases Vaccine Production Mode & Process
  6. 9.2 Porcine Circovirus Diseases Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Circovirus Diseases Vaccine Distributors
  9. 9.2.3 Porcine Circovirus Diseases Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst